NCT03632239
Reverse Phenotyping Core
Enrolling by Invitation
Not specifiedAges 4+ObservationalNational Human Genome Research Institute (NHGRI)Government-funded
~1,000 participants
Updated 2026-06-11 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hypotheses from RPC to be tested
Measured over yearly
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Clesson E Turner, M.D. · PRINCIPAL_INVESTIGATOR · National Human Genome Research Institute (NHGRI)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Participants in the RPC Genomic Data Archive must have exome or genome sequencing available that collaborators have permission to share for inclusion in our resource.
Participants in the RPC Genomic Data Archive must be re-contactable by the primary study team (e.g., the collaborator who contributes their data must be able to contact the participants).
All participants must be \>= 4 years old.
Health Perceptions Survey Criterion: Only adult participants who are able to provide consent for themselves will be eligible for this portion of the study.
What this trial measures
- Hypotheses from RPC to be testedyearly
RPC will generate data regarding phenotypic consequences of genetic variants